In the elderly, amiodarone is probably the safest drug for short-term administration ... There are serious concerns about the proarrhythmic effects of class I agents in the elderly, especially ...
However, the efficacy of antiarrhythmic agents has not been rigorously evaluated in patients with ARVC, and limited data are available to support such use of these drugs. The Multidisciplinary ...
adverse events that were attributed to antiarrhythmic drug treatment included death from pulmonary toxic effects in 1 patient (0.5%) and nonfatal adverse events in 46 patients (21.6%). Among ...
Drugs recommended by the European Resuscitation Council are those outlined for use in VT. Lignocaine is a class IB antiarrhythmic drug and is the first choice for VT. It is given intravenously in a ...
14, 2024 /PRNewswire/ -- HUYABIO International today announced the presentation of new patient data for HBI-3000, an antiarrhythmic drug (AAD ... estimates that 12.1 million people ...